{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:27Z","timestamp":1707525027184},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,5]]},"DOI":"10.7759\/cureus.38581","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T12:31:52Z","timestamp":1683289912000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Mucosal Melanoma of the Lip With GNA11 Mutation in a 23-Year-Old Pregnant Woman"],"prefix":"10.7759","author":[{"given":"Shivam","family":"Khatri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Kashfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X17695001","article-title":"Melanoma in pregnancy","volume":"10","author":"Still R","year":"2017","unstructured":"Still R, Brennecke S. Melanoma in pregnancy. Obstet Med. 2017, 10:107-12. 10.1177\/1753495X17695001","journal-title":"Obstet Med"},{"key":"ref2","article-title":"Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification","volume":"28","author":"Rastrelli M","year":"2014","unstructured":"Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014, 28:1005-11.","journal-title":"In Vivo"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23250","article-title":"Primary malignant melanoma of the esophagus in a 76-year-old female","volume":"14","author":"Kashfi S","year":"2022","unstructured":"Kashfi S, Marneni N, Sharma S, Vigoda I. Primary malignant melanoma of the esophagus in a 76-year-old female. Cureus. 2022, 14:e23250. 10.7759\/cureus.23250","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.5070\/D337T8G7BF","article-title":"Case report: mucosal melanoma of the lip and the cheek","volume":"14","author":"Disky A","year":"2008","unstructured":"Disky A, Campos D, Benchikhi H. Case report: mucosal melanoma of the lip and the cheek. Dermatol Online J. 2008, 14:20.","journal-title":"Dermatol Online J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-015-1459-3","article-title":"Primary malignant mucosal melanoma of the upper lip: a case report and review of the literature","volume":"8","author":"Lamichhane NS","year":"2015","unstructured":"Lamichhane NS, An J, Liu Q, Zhang W. Primary malignant mucosal melanoma of the upper lip: a case report and review of the literature. BMC Res Notes. 2015, 8:499. 10.1186\/s13104-015-1459-3","journal-title":"BMC Res Notes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2015.05.021","article-title":"Primary malignant melanoma of the lip: a report of 48 cases","volume":"73","author":"Jing G","year":"2015","unstructured":"Jing G, Wu Y, Song H, Ren G, Wang R, Guo W. Primary malignant melanoma of the lip: a report of 48 cases. J Oral Maxillofac Surg. 2015, 73:2232-40. 10.1016\/j.joms.2015.05.021","journal-title":"J Oral Maxillofac Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-516","article-title":"GNAQ mutation in a patient with metastatic mucosal melanoma","volume":"14","author":"Kim CY","year":"2014","unstructured":"Kim CY, Kim DW, Kim K, Curry J, Torres-Cabala C, Patel S. GNAQ mutation in a patient with metastatic mucosal melanoma. BMC Cancer. 2014, 14:516. 10.1186\/1471-2407-14-516","journal-title":"BMC Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jop.12358","article-title":"Mutation scanning of BRAF, NRAS, KIT, and GNAQ\/GNA11 in oral mucosal melanoma: a study of 57 cases","volume":"45","author":"Lyu J","year":"2016","unstructured":"Lyu J, Wu Y, Li C, Wang R, Song H, Ren G, Guo W. Mutation scanning of BRAF, NRAS, KIT, and GNAQ\/GNA11 in oral mucosal melanoma: a study of 57 cases. J Oral Pathol Med. 2016, 45:295-301. 10.1111\/jop.12358","journal-title":"J Oral Pathol Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.adoms.2021.100165","article-title":"Desmoplastic melanoma of the lower lip: a case report","volume":"4","author":"Treacy S","year":"2021","unstructured":"Treacy S, Traynor K, Leonard N, Gilbride M, Wilson M. Desmoplastic melanoma of the lower lip: a case report. A Oral Maxillofac Surg. 2021, 4:1-2. 10.1016\/j.adoms.2021.100165","journal-title":"A Oral Maxillofac Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-022-01225-z","article-title":"Evolving treatment approaches to mucosal melanoma","volume":"24","author":"Zhang S","year":"2022","unstructured":"Zhang S, Zhang J, Guo J, Si L, Bai X. Evolving treatment approaches to mucosal melanoma. Curr Oncol Rep. 2022, 24:1261-71. 10.1007\/s11912-022-01225-z","journal-title":"Curr Oncol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma","volume":"388","author":"Patel SP","year":"2023","unstructured":"Patel SP, Othus M, Chen Y, et al.. Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N Engl J Med. 2023, 388:813-23. 10.1056\/NEJMoa2211437","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.09.008","article-title":"Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy","volume":"104","author":"Menzer C","year":"2018","unstructured":"Menzer C, Beedgen B, Rom J, et al.. Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy. Eur J Cancer. 2018, 104:239-42. 10.1016\/j.ejca.2018.09.008","journal-title":"Eur J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000506327","article-title":"Successful treatment of a patient with anti-PD1 antibody-resistant advanced mucosal melanoma with nivolumab, ipilimumab plus denosumab combination therapy","volume":"13","author":"Fujimura T","year":"2020","unstructured":"Fujimura T, Kambayashi Y, Ohuchi K, et al.. Successful treatment of a patient with anti-PD1 antibody-resistant advanced mucosal melanoma with nivolumab, ipilimumab plus denosumab combination therapy. Case Rep Oncol. 2020, 13:271-5. 10.1159\/000506327","journal-title":"Case Rep Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100262","article-title":"Immune checkpoint inhibitor administration during pregnancy: a case series","volume":"6","author":"Andrikopoulou A","year":"2021","unstructured":"Andrikopoulou A, Korakiti AM, Apostolidou K, Dimopoulos MA, Zagouri F. Immune checkpoint inhibitor administration during pregnancy: a case series. ESMO Open. 2021, 6:100262. 10.1016\/j.esmoop.2021.100262","journal-title":"ESMO Open"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.6096","article-title":"Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial","volume":"311","author":"Carvajal RD","year":"2014","unstructured":"Carvajal RD, Sosman JA, Quevedo JF, et al.. Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA. 2014, 311:2397-405. 10.1001\/jama.2014.6096","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20758","article-title":"Combined carboplatin and paclitaxel therapy improves overall survival in patients with nivolumab-resistant acral and mucosal melanoma","volume":"186","author":"Maeda T","year":"2022","unstructured":"Maeda T, Hiura A, Uehara J, Toyoshima R, Nakagawa T, Yoshino K. Combined carboplatin and paclitaxel therapy improves overall survival in patients with nivolumab-resistant acral and mucosal melanoma. Br J Dermatol. 2022, 186:361-3. 10.1111\/bjd.20758","journal-title":"Br J Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00902","article-title":"Randomized phase II study of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced mucosal melanoma","volume":"39","author":"Yan X","year":"2021","unstructured":"Yan X, Sheng X, Chi Z, et al.. Randomized phase II study of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced mucosal melanoma. J Clin Oncol. 2021, 39:881-9. 10.1200\/JCO.20.00902","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/147245-primary-mucosal-melanoma-of-the-lip-with-gna11-mutation-in-a-23-year-old-pregnant-woman","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:42Z","timestamp":1707508662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/147245-primary-mucosal-melanoma-of-the-lip-with-gna11-mutation-in-a-23-year-old-pregnant-woman"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.38581","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,5]]}}}